PMID: 6970015Jan 1, 1981Paper

Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass

Annals of Surgery
A T CullifordF C Spencer

Abstract

The activated clotting time (ACT) with a Hemochron system for determining heparin requirements during cardiopulmonary bypass surgery, (CPB) accompanied by hemodilution and hypothermia was evaluated using plasma heparin levels as a standard. In 28 patients who were administered a standard heparin regimen (300 units/kg prebypass, 8000 units in the pump prime and 100 units/kg hourly during CPB) mean prebypass plasma heparin was 4 units/ml, and ACT was 493 seconds. During CPB mean plasma heparin decreased significantly (p < 0.001) to 3.1 units/ml, whereas mean ACT increased significantly (p < 0.001) to 674 seconds. The mean protamine requirement predicted from ACT was significantly higher (43%) than predicted from plasma heparin levels or actual protamine administered. The ACT neither accurately reflected plasma heparin during CPB nor predicted protamine requirements. The fixed-dose regimen employed, however, prevented both intraoperative thrombosis, assessed clinically in all patients, and clotting on six arterial line filters, as determined by scanning EM, despite wide variations in ACT and plasma heparin levels during surgery.

Associated Clinical Trials

References

Sep 1, 1973·Stain Technology·T Sato, M Shamoto

❮ Previous
Next ❯

Citations

Jun 13, 2006·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·André VincentelliSylvain Bélisle
Jan 1, 1995·The Annals of Thoracic Surgery·G J DespotisD G Lappas
Sep 1, 1994·The Annals of Thoracic Surgery·N TabuchiW van Oeveren
Aug 14, 2002·The Annals of Thoracic Surgery·J F Matthias BechtelClaus Bartels
Feb 1, 1997·The Annals of Thoracic Surgery·S O Turner-GomesW G Williams
May 13, 1999·The Annals of Thoracic Surgery·H I Flom-HalvorsenF Brosstad
Oct 18, 2003·Anesthesiology Clinics of North America·Linda Shore-Lesserson
Aug 1, 1997·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·S BannanP Martin
Sep 13, 2007·Blood·Shayela SuvarnaGowthami M Arepally
Feb 21, 2002·Journal of Cardiothoracic and Vascular Anesthesia·Linda Shore-Lesserson
Jul 28, 2004·Intensive Care Medicine·Domenico PaparellaMichael R Buchanan
Jun 25, 2013·Journal of Cardiothoracic and Vascular Anesthesia·Stanley D BrauerBrian S Bull
Feb 6, 2008·Journal of Cardiothoracic and Vascular Anesthesia·Robert D SlightPankaj S Mankad
Dec 1, 1989·European Journal of Vascular Surgery·N N WilliamsD Bouchier-Hayes
Aug 7, 2007·Journal of Cardiothoracic and Vascular Anesthesia·Michael T GanterChristoph K Hofer
Dec 17, 2008·European Journal of Haematology·Joost Jair van VeenMike Makris
Feb 15, 2012·Journal of Thrombosis and Haemostasis : JTH·S J DavidsonA A Kelleher
Jul 14, 2010·British Journal of Haematology·David J PerrySue Mallett
Oct 1, 1987·Journal of Cardiothoracic Anesthesia·G P GravleeA L Pauca
Mar 9, 1999·Journal of Cardiothoracic and Vascular Anesthesia·J C FitchR L Hines
Nov 1, 1990·Journal of Clinical Anesthesia·E Inada
Oct 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·J BoldtG Hempelmann
Jul 6, 2004·Annales Françaises D'anesthèsie Et De Rèanimation·B JudeUNKNOWN Groupe d'intérêt en hémostase périopératoire
Feb 1, 1995·Journal of Cardiothoracic and Vascular Anesthesia·M BlombäckK Carlsson
Dec 1, 1987·European Journal of Vascular Surgery·R J PorteT H Groenland
May 29, 2001·American Heart Journal·J H Levy
May 1, 1992·The Annals of Thoracic Surgery·F HorkayD R Walker
Apr 1, 1993·The Annals of Thoracic Surgery·S Westaby
Jun 1, 1983·The Annals of Thoracic Surgery·W P FiserT J Vecchio
Jul 20, 2014·Journal of Cardiothoracic and Vascular Anesthesia·Alan FinleyKelly Grogan
Nov 23, 2010·Journal of the American College of Cardiology·Colleen E GruenwaldBrian W McCrindle
Jun 16, 2005·The Annals of Pharmacotherapy·Sarah A SpinlerMaureen A Smythe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.